Scott Carter Foundation and CureSearch fund Clinical Trial for DIPG

Paula Carter, founder of the Scott Carter Foundation in Tulsa, OK, joins us with Caitlyn Barrett, National Director of Research and Programs for CureSearch, to discuss their collaboration in supporting a new clinical trial for DIPG. The Scott Carter Foundation has been supporting childhood cancer research for three decades inā€¦

Continue reading

CureSearch CEO Laura Thrall

CCTR interviews Laura Thrall, CEO of CureSearch since 2012, with five years of refining purpose, innovation, and efficiency in the medical research industry to benefit pediatric cancer research funding. The primary goal and measure of the success of any new policy should be evident in patient care, access, and improvedā€¦

Continue reading

DIPG Awareness Week in California, May 25-31

Wednesday, May 20, Santa Clarita, CA–DIPG, diffuse intrinsic pontine glioma, is a pediatric brain tumor that is invariably terminal with no progress made to that effect in over 35 years of clinical record. Ā DIPG is responsible for roughly 80% of pediatric brain tumor deaths annually[1], the leading cause of cancer-relatedā€¦

Continue reading

Our Mission 2014

This post is a repeat of our home page, the content of which is very important yet is often overlooked. Ā Here the links are kept intact for easy reference. Ā Also, our literature is offered here as well. Ā  PRWeb press release Ā  Ā LEAFLET brochureĀ  Ā Ā DESCRIPTION of PurposeĀ  Ā Did You Know?ā€¦

Continue reading